Magnetic resonance imaging in patients with ductal carcinoma in situ: Routine, selective, or not at all?

Annals of Surgical Oncology

Volumn 21, Issue 5, 2014, Pages 1510-1511

  Margenthaler, Julie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ALGORITHM; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL DECISION MAKING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; EDITORIAL; FAMILIAL CANCER; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84898870314     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3425-4     Document Type: Editorial

References (12)

1. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196:389-97.
2. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-49.
3. Pediconi F, Catalano C, Padula S, et al. Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer? Breast Cancer Res Treat. 2007;106:65-74. (Pubitemid 47498089)
4. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89. (Pubitemid 46535708)
5. Menell JH, Morris EA, Dershaw DD, et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11(6):382-90. (Pubitemid 41743410)
6. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet. 2007;370(9586):485-92. (Pubitemid 47214635)
7. Pilewskie M, Olcese C, Eaton A, et al. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. doi: 10.1245/s10434-013-3424-5.
8. Pilewskie M, Kennedy C, Shappell C, et al. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol. 2013;20:1522-9.
9. Pettit K, Swatske ME, Gao F, et al. The impact of breast MRI on surgical decision-making: Are patients at risk for mastectomy? J Surg Oncol. 2009;100(7):553-8.
10. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41. (Pubitemid 35176242)
11. Solin LJ, Orel SG, Hwang Wei-Ting, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386-91. (Pubitemid 351171689)
12. Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breast on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725-31. (Pubitemid 39386618)